Medicis Pharmaceutical

Medicis Pharmaceutical Corporation operates as a specialty pharmaceutical company in the United States and Canada.

Medicis Pharmaceutical Corporation operates as a specialty pharmaceutical company in the United States and Canada. The company focuses primarily on helping patients attain a healthy and youthful appearance and self-image through the development and marketing in the U.S. of products for the treatment of dermatological, aesthetic and podiatric conditions. It also markets products in Canada for the treatment of dermatological and aesthetic conditions The company offers a range of products addressing various conditions or aesthetic improvements, including facial wrinkles, acne, fungal infections, rosacea, hyperpigmentation, photoaging, psoriasis, skin and skin-structure infections, seborrheic dermatitis and cosmesis (improvement in the texture and appearance of skin). The company offers 18 branded products. Its primary brands are PERLANE (hyaluronic acid), RESTYLANE (hyaluronic acid), SOLODYN (minocycline HCl, USP), TRIAZ (benzoyl peroxide), VANOS (fluocinonide) Cream 0.1%, and ZIANA (clindamycin phosphate 1.2% and tretinoin 0.025%) Gel. The company also sells various other products that it considers less critical to its business. It has various products under development, ranging from new products to existing product line extensions and reformulations of existing products. Products Dermal Restorative Products The company's principal branded dermal restorative products include: RESTYLANE, PERLANE, RESTYLANE FINE LINES and RESTYLANE SUBQ are injectable, transparent, stabilized hyaluronic acid gels, which require no patient sensitivity tests in advance of product administration.